Study S002631

A Prospective, Single Center, Open-label Study Evaluating the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 Agonists

ClinicalTrials.gov record

Registration

Registration: NCT07558603
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 50
Start: 2026-04-20
Primary completion: 2026-08-30
Lead sponsor: Goldman, Butterwick, Fitzpatrick and Groff
Conditions: Laxity; Skin
Interventions: DRUG:On GLP1 plus HRT; DRUG:On GLP1 Only
Results posted: FALSE

Registered primary outcomes

Modified Griffith Scale [Baseline, Week 6 and Week12]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.